Position Your Company at the Forefront of Gene Editing
With 2025 being yet another momenteous year for genome editing therapeutics, attendees greatly benefited from connecting with the experts actively advancing the next wave of safe and durable therapies at the 6th Genome Editing Therapeutics Summit.
This much-loved forum provided you with an unmatched platform to showcase your company’s services, expertise, solutions and brand to the growing number of biopharma, continuing to incorporate gene editing into their development.
Reach out today to discuss how we can support you in establishing strong relationships with this unique group through one of our trusted partnership positions in 2026
2025 Audience Composition
Company Type
Attendee Seniority
Attending Companies Include